A Phase II Randomized, Double Blinded Study of the Peroxisome Proliferator-Activated Receptor Gamma Agonist, Efatutazone vs. Placebo in Patients with Previously Treated, Unresectable Myxoid Liposarcoma

Type of Cancer
Skin and Soft Tissue

Site
Hackensack

Sponsor
Alliance

Protocol Number
A091202

To Learn More Call
201-510-0910